UV Sterilization in Texas

Cleanis Inc manufactures specialized hygiene and waste management solutions for hospitals, healthcare facilities, and home healthcare settings. The company's flagship product line, CareBag®, comprises disposable bedpan and commode pail liners, emesis bags, urinal bags, and toilet bowl liners—all designed with super-absorbent pads to reduce direct contact with bodily waste, minimize splashing and spilling, and improve nursing workflow and safety. The CareBag® line is available in both standard and antimicrobial formulations. Cleanis also produces GelMax®, a line of soluble solidifier pods and super-absorbent mats for fluid containment; Aqua® wash and shampoo gloves for patient hygiene; and the PottyMate® potty liner for pediatric and home care applications. The company's UVC disinfection product portfolio includes the AUVS Box Advanced Ultra-Violet System, mobile UVC units (MRS45-12, MRS33-8, MRS14-4), wall and pendant-mounted fixtures, and Smart OR and Smart EVS packages for operating room and environmental services disinfection. CareBag® products are manufactured using 100% post-consumer recycled plastic and have demonstrated 30–50% reduction in C. difficile infections in clinical practice. Cleanis holds patent-pending status for its recycled-plastic CareBag® design and reports 50% lower greenhouse gas emissions compared to traditional absorbent liners. The company serves acute-care hospitals, critical access facilities, and home healthcare providers across the US and Canada, with international operations supported through a European office.

Xenex Disinfection Services is a San Antonio-based medical technology company founded in 2008 by epidemiologists Dr. Mark Stibich and Dr. Julie Stachowiak. The company specializes in UV light-based disinfection technology designed to reduce healthcare-associated infections (HAIs) in hospital environments. The flagship product is the LightStrike™ Germ-Zapping Robot, which uses patented pulsed xenon full-spectrum UV light to achieve 99% pathogen reduction on treated surfaces in cycle times as fast as 2 minutes, without chemicals. The technology is FDA-authorized for whole-room microbial reduction and proven effective against resistant pathogens including MRSA, C. difficile, A. baumannii, and E. cloacae. Xenex serves over 350 healthcare facilities across North America, Europe, and Africa, offering integrated disinfection programs that combine robotics with training, advanced workflow consulting, and digital tracking systems to enhance room turnover, infection prevention, and outbreak control.